Announcements

Framework for Biomarker Evidentiary Criteria Released

December 6, 2016 — The Foundation for the National Institutes of Health (FNIH) announced today the release of the “Framework for Defining Evidentiary Criteria for Biomarker Qualification.” Developed in partnership with government and industry stakeholders, the framework defines the level of evidence needed to support qualification of biological markers (biomarkers). The document is a result of a broad-based effort by the FNIH, the U.S.

Training the Next Generation of Clinician Scientists through the NIH Medical Research Scholars Program (MRSP) Q&A with esteemed MRSP Alum Kyle Vining, DDS, Harvard University

October 25, 2016 — This fall, 52 medical and dental students began intensive research training at the National Institutes of Health (NIH) through the Medical Research Scholars Program (MRSP). This one-year program offers students opportunities to engage in research early in their careers, while addressing the critical need for a pipeline of talented scientists capable of turning discovery into improved health.

Salk Institute Presents FNIH Board Member Solomon H. Snyder, M.D., with Medal for Research Excellence

October 5, 2016 — Renowned neuroscientist Solomon H. Snyder, M.D., FNIH Board Vice Chairman for Science, was awarded the Salk Institute’s Medal for Research Excellence. This award, which has only been bestowed twice since the Salk Institute was established 56 years ago, honors individuals making significant contributions to basic science research with particular advances to policy, humanities, human health or the Institute.

The FNIH’s Statement on the Democratic Staff Report of the Committee on Energy and Commerce

May 23, 2016 — This morning, the Democratic Staff of the Committee on Energy and Commerce issued a report on the Sports and Health Research Program (SHRP), a partnership among the National Institutes of Health (NIH), National Football League (NFL) and the Foundation for the National Institutes of Health (FNIH). The following is the FNIH’s response to the report.  

The FNIH Launches New Project to Evaluate the Effectiveness of Liquid Biopsies as Biomarkers in Colorectal Cancer Patients

May 3, 2016 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium is launching a research partnership to determine whether liquid biopsies can be used instead of traditional solid tumor biopsies for diagnosing and monitoring metastatic colorectal cancer.

The FNIH Launches New Program Focused on Assessment of Cardiovascular Risk Biomarkers in U.S. Population

March 24, 2016 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a 4-year project to transform our ability to characterize risk for developing cardiovascular disease. The project is poised to improve identification and care of at-risk patients through a comprehensive investigation that will measure novel biomarkers in a national study consisting of more than 25,000 samples.